Human Biomaterials Policy Announced

The University at Buffalo is committed to serving the academic research community and industry partners by providing a supply of high-quality biomaterials to support basic and translational research through centralized and standardized services for the collection, processing, management, and distribution of biobanking assets. The UB Biorepository was created to establish a centralized resource of high-quality, deeply annotated biospecimens to enable research and technology development, including new diagnostic tests and therapeutics, advancing the goals of the research community and industry partners.

Principal investigators (PIs) and collaborators must meet the minimum regulatory standards outlined in the UB Biorepository Manual of Operations and in the event that those requirements cannot be met, PIs must utilize the UB Biorepository for the collection and storage of human biomaterials. All samples must be registered in the UB Biorepository Laboratory Information Management System (LIMS) irrespective of processing and storage location. PIs maintain control and use of the samples, as well as control over any data linked to the samples.

All UB programs, studies, and departmental activities that receive university funding or have grants and/or contracts for biosample collection activities shall use the UB Biorepository for the collection and storage of biomaterials as it pertains to that grant or project, unless the PI is able to demonstrate that their lab is compliant under the same conditions and to the same standards under which the UB Biorepository operates as outlined in the UB Biorepository operations manual. All samples, regardless of storage location, must be entered into the university-wide LIMS system, managed by the UB Biorepository.